Two distinct groups of colorectal cancer in inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 15, Issue 1, 2009, Pages 9-16

  Brackmann, Stephan ^a   Andersen, Solveig Norheim ^a   Aamodt, Geir ^a   Roald, Borghild ^a   Langmark, Frøydis ^b   Clausen, Ole P F ^c   Aadland, Erling ^d   Fausa, Olav ^c   Rydning, Andreas ^a   Vatn, Morten H ^a,c  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Colorectal neoplasm; Crohn's disease; Histopathology; Inflammatory bowel diseases; Risk factors; Ulcerative colitis

Indexed keywords

ADENOCARCINOMA; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; COLORECTAL CANCER; COLORECTAL DYSPLASIA; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DYSPLASIA; ENTERITIS; FAMILY HISTORY; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; ONSET AGE; POLYPOSIS; PRIORITY JOURNAL; SIGNET RING CARCINOMA; TUMOR DIFFERENTIATION; ADOLESCENT; ADULT; CLASSIFICATION; CLINICAL TRIAL; COHORT ANALYSIS; COLLOID CARCINOMA; COLORECTAL TUMOR; MASS SCREENING; MULTICENTER STUDY; PATHOLOGY; PROGNOSIS; RISK FACTOR; ULCERATIVE COLITIS;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADOLESCENT; CARCINOMA, SIGNET RING CELL; COHORT STUDIES; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 61949273949     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20542     Document Type: Article

References (34)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526-535.
2. Jess T, Gamborg M, Matzen P, et al. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724-2729.
3. Collins PD, Mpofu C, Watson AJ, et al. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2006:CD000279.
4. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990; 323:1228-1233.
5. Ekbom A, Helmick C, Zack, M, et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet. 1990;336: 357-359.
6. Langholz E, Munkholm P, Davidsen M, et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992;103: 1444-1451.
7. Rutegard JN, Ahsgren LR, Janunger KG. Ulcerative colitis. Colorectal cancer risk in an unselected population. Ann Surg. 1988;208:721-724.
8. Lashner BA, Silverstein MD, Hanauer SB. Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci. 1989;34:1536-1541.
9. Jess T, Loftus EV, Jr., Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted county, Minnesota. Gastroenterology. 2006;130:1039-1046.
10. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91:854-862.
11. Rubio CA. Serrated neoplasias and de novo carcinomas in ulcerative colitis: a histological study in colectomy specimens. J Gastroenterol Hepatol. 2007;22:1024-1031.
12. Sugita A, Sachar DB, Bodian C, et al. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut. 1991;32:167-169.
13. Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut. 1988;29: 206-217.
14. Brackmann SA, Andersen SN, Aamodt G, Langmark F, Clausen OPF, Aadland E, Fausa O, Rydning A, Vatn MH. Time to CRC in IBD. Relationship between clinical parameters and the colitis-CRC interval in a cohort of patients with CRC in IBD. Scand J Gastroenterol. 2008; 43:accepted for publication.
15. Karvellas CJ, Fedorak RN, Hanson J, et al. Increased risk of colorectal cancer in ulcerative colitis patients diagnosed after 40 years of age. Can J Gastroenterol. 2007;21:443-446.
16. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994;35:950-954.
17. Svrcek M, Cosnes J, Beaugerie L, et al. Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis. Histopathology. 2007;50:574-583.
18. Connell WR, Talbot IC, Harpaz N, et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut. 1994; 35:1419-1423.
19. Taylor BA, Pemberton JH, Carpenter HA, et al. Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum. 1992;35:950-956.
20. Ransohoff DF, Riddell RH, Levin B. Ulcerative colitis and colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum. 1985;28:383-388.
21. von Herbay A, Herfarth C, Otto HF. Cancer and dysplasia in ulcerative colitis: a histologic study of 301 surgical specimen. Z Gastroenterol. 1994;32:382-388.
22. Aaltonen LA, Hamilton SR, World Health Organization, et al. Pathology and genetics of tumours of the digestive system. World Health Organization classification of tumours. Lyon, Oxford: IARC Press, Oxford University Press (distributor); 2000.
23. Sobin LH, Wittekind C, International Union against Cancer. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002.
24. Jass JR. Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol. 1986;39:585-589.
25. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931-968.
26. Morson BC, Jass JR, Sobin LH. Precancerous lesions of the gastrointestinal tract: a histological classification. London; Philadelphia: Baillière Tindall; 1985.
27. Andersen SN, Lovig T, Clausen OP, et al. Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations. Gut. 1999;45:686-692.
28. Rutter M, Sauders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451-459.
29. Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133:1099-1105; quiz 1340-1341.
30. Rabinovitch PS, Dziadon S, Brentnall TA, et al. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res. 1999;59:5148-5153.
31. Issa JP, Ahuja N, Toyota M, et al. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001;61:3573-3577.
32. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology. 1992;103:1611-1620.
33. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124:880-888.
34. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004;53:256-260.